WebDisclosure WebDisclosure
Basculer en Français
10940 Companies
239027 Keywords
167902 Articles
128526 Press releases
Headlines Articles Press releases SENSORION Remove
  1. Home
  2. Companies
  3. SENSORION
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 05/28/2024 at 07:30, 2 years 3 months ago

    Inside Information / Other news releases

    Sensorion announces its participation in upcoming investor conferences in June 2024 to present its novel therapies for hearing loss disorders. The company will attend conferences in New York, Miami, and Lyon
    Biotechnology Investor Conferences June 2024 Sensorion Hearing Loss Disorders
    Logo of SENSORION
  • PRESS RELEASE

    published on 05/28/2024 at 07:30, 2 years 3 months ago

    Informations privilégiées / Autres communiqués

    Sensorion annonce sa participation à des conférences investisseurs en juin 2024. Inscrivez-vous aux événements clés de l'entreprise de biotechnologie spécialisée dans les thérapies de perte auditive
    Biotechnologie Conférences Investisseurs Événements Sensorion Thérapies Auditives
    Logo of SENSORION
Previous page
1 ... 17 18
Accesswire
  • Published on 09/05/2026 at 04:05, 2 days 21 hours ago

    Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update

  • Published on 09/04/2026 at 23:30, 3 days 2 hours ago

    FutureGen Industries Announces Shares for Debt Settlement

  • Published on 09/04/2026 at 23:00, 3 days 2 hours ago

    Golden Minerals Announces Management Change and Argentine Project Update

  • Published on 09/04/2026 at 22:30, 3 days 3 hours ago

    Panther Minerals Closes Brokered Private Placement of $3,000,000

  • Published on 09/04/2026 at 14:30, 3 days 11 hours ago

    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/07/2026 at 19:19, 6 hours 21 minutes ago

    EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Sales and Adjusted EBIT in Q2 2026/27 above prior-year level – FY outlook maintained

  • Published on 09/07/2026 at 19:00, 6 hours 40 minutes ago

    PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 31 août 2026 au 4 septembre 2026

  • Published on 09/07/2026 at 18:42, 6 hours 57 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 09/07/2026 at 18:00, 7 hours 40 minutes ago

    E-PANGO: e-Pango organise un webinaire avec ses actionnaires

  • Published on 09/07/2026 at 17:45, 7 hours 55 minutes ago

    VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social

View all EQS
Les Echos
  • Published on 09/07/2026 at 19:55, 5 hours 44 minutes ago

    TFF GROUP CREE TFF UPCYCLING

  • Published on 09/07/2026 at 19:00, 6 hours 40 minutes ago

    Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026

  • Published on 09/07/2026 at 19:00, 6 hours 40 minutes ago

    Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026

  • Published on 09/07/2026 at 18:05, 7 hours 35 minutes ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026

  • Published on 09/07/2026 at 18:05, 7 hours 35 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy